HomeFDMT • NASDAQ
add
4D Molecular Therapeutics Inc
Previous close
$7.99
Day range
$7.53 - $8.11
Year range
$7.32 - $36.25
Market cap
404.84M USD
Avg Volume
792.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.00K | -99.99% |
Operating expense | 12.65M | 38.84% |
Net income | -43.84M | -327.49% |
Net profit margin | -1.46M | -2,879,004.28% |
Earnings per share | -0.79 | -229.17% |
EBITDA | -49.94M | -284.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 501.89M | 57.01% |
Total assets | 604.03M | 67.04% |
Total liabilities | 51.08M | 61.24% |
Total equity | 552.95M | — |
Shares outstanding | 46.23M | — |
Price to book | 0.75 | — |
Return on assets | -20.88% | — |
Return on capital | -21.67% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -43.84M | -327.49% |
Cash from operations | -29.39M | -2,409.91% |
Cash from investing | 27.30M | -8.94% |
Cash from financing | 568.00K | -94.62% |
Net change in cash | -1.52M | -103.87% |
Free cash flow | -15.55M | -24,307.78% |
About
Founded
2013
Headquarters
Website
Employees
201
